Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3734367017 | Palivizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3734368010 | Product containing only palivizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2820591000001113 | Palivizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2820601000001116 | Palivizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Palivizumab | Has active ingredient | Palivizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Palivizumab | Is a | Product containing palivizumab | true | Inferred relationship | Existential restriction modifier | ||
| Palivizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Palivizumab | Plays role | Antiviral therapeutic role | false | Inferred relationship | Existential restriction modifier | ||
| Palivizumab | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Palivizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only palivizumab in parenteral dose form (medicinal product form) | Is a | True | Palivizumab | Inferred relationship | Existential restriction modifier | |
| Palivizumab 100mg powder and solvent for solution for injection vials | Is a | True | Palivizumab | Inferred relationship | Existential restriction modifier | |
| Palivizumab 50mg/0.5ml solution for injection vials | Is a | True | Palivizumab | Inferred relationship | Existential restriction modifier | |
| Palivizumab 100mg/1ml solution for injection vials | Is a | True | Palivizumab | Inferred relationship | Existential restriction modifier | |
| Palivizumab 50mg powder and solvent for solution for injection vials | Is a | True | Palivizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR